Abstract / Free Radical Biology and Medicine 65 (2013) S23–S56
signiﬁcantly positively correlated with body mass index (BMI) and hip circumference in obese group. Erythrocyte SOD showed signiﬁcant negative correlation with BMI in obese group. Furthermore, erythrocyte SOD were signiﬁcantly negative correlated HDL-cholesterol in non-obese group. The increase in adipose tissue as a result of obesity causes a chronic inﬂammation which in turn may cause increases in lipid peroxidation and decreases in erythrocyte cytoprotectic. So our result suggest that obesity even in the absence of other confounding factors such as diabetes and hypertension, is an independent risk factor for lipid peroxidation and increase in oxidative stress. http://dx.doi.org/10.1016/j.freeradbiomed.2013.08.016
Serum VEGF, CD40L and NO levels in Peripheral Arterial Disease Eda Becer a, Elif Özkök b, Fatih Yanar c, Yılmaz Başar c, Nihal Salmayenli d, Güldal Mehmetçik a a
Department of Biochemistry, Faculty of Pharmacy, Near East University, Nicosia, Cyprus b Department of Neuroscience, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey c Department of General Surgery, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey d Central Laboratory of Clinical Biochemistry, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
Peripheral arterial disease (PAD) is closely associated with systemic atherosclerosis and thrombosis. It has been shown that serum CD40 ligand, a transmembrane protein expressed on endothelial cells, is related to atherosclerosis from early stages to late severe thrombosis. Atherogenesis begins with endothelial dysfunction. The vascular endothelium plays a critical role in the atherothrombogenesis. The production of endothelial mediators are affected by injury of endothelium. Vascular endothelial growth factor (VEGF) is a potent endothelial cell-speciﬁc mitogen. It has been shown that VEGF plasma concentrations increased in patients with PAD. In the light of these ﬁndings, we aimed to research the levels of serum CD40L, VEGF and nitrite/nitrate levels in patients with PAD. We enrolled 106 patients with PAD and 65 age-matched healthy controls into study. The concentrations of VEGF, sCD40 ligand were determined using with ELISA method in serum samples. The ﬁnal products of NO in vivo are nitrite (NO2) and nitrate (NO3). We measured serum nitrite (NO2) and nitrate (NO3) levels of the ﬁnal product of NO by colorimetric method. Statistical analyses were performed using the SPSS software package, revision 15.0. p value o0.05 was considered signiﬁcant. There was no difference in age between controls and patients. The mean plasma concentrations of VEGF (po 0.001), sCD40L (po0.001) were higher in PAD patients than those of the controls. In contrast, the concentrations of total nitrate and nitrite were lower in patients with PAD than those of the controls (p o 0.05). Increased CD40L that could play an important role in human atherosclerosis may be an indicator for PAD. Also, increased VEGF levels were compatible with the results of the other studies in PAD. However, decreased total nitrate/nitrite levels may be due to reduced synthesis and inactivation of NO in patients with PAD.
Carbonylated HeLa cell proteome Ravi Chand Bollineni a,b, Ralf Hoffmann a,b, Maria Fedorova a,b a Institute of Bioanalytical Chemistry, Faculty of Chemistry and Mineralogy, Center for Biotechnology and Biomedicine, Universität Leipzig, Leipzig, Germany b Center for Biotechnology and Biomedicine, Universität Leipzig, Leipzig, Germany E-mail address: [email protected]
Protein oxidation is considered as a major hallmark of aging and age-related disorders. Carbonylation, a major class of oxidative protein modiﬁcations, is widely accepted as biomarker of oxidative stress, aging and age-related disorders. However, studies of cellular/protein distribution and biological role of protein carbonylation are limited. Here we present a proteome-wide proﬁling of carbonylated proteins from HeLa cells treated with hydrogen peroxide, using our previously published LCxLC-(LDI-TOF)-ESI-Orbitrap-MS/MS approach . This high throughput proteomic approach identiﬁed a total of 210 carbonylated proteins. Surprisingly, when compared with entries of cell death database (2480 entries), one third of carbonylated HeLa proteins were shown to be regulated during apoptosis, whereas 41 were involved in autophagy (19%) and nine in mitotic catastrophe (4%). STRING functional interaction analysis of the ﬁrst set of carbonylated proteins regulated during apoptosis revealed several nodes with proteins involved in nuclear-cytoskeleton anchoring, protein synthesis, vesicle transport and cell proliferation/growth, moreover proteins involved in autophagy were mostly ribonuclear and cytoskeletal proteins. Main functional interaction between carbonylated proteins not present in cell death database (119 proteins) were connected with centrosome/spindle organization (chromosome segregation during cell division). Additionally, high throughput MS based approach allowed us to identify 643 carbonylation sites within 210 proteins, out of which 284 modiﬁcation sites were found on lysine (44%), 121 on arginine and threonine (19% each), 117 on proline (18%). This high number of carbonylated sequences allowed us to perform a statistically signiﬁcant analysis of sequence motifs associated with carbonylation sites. Motif analysis revealed signiﬁcant enrichment of basic amino acids (lysine and arginine) around 7 10 positions from the modiﬁcation sites (especially at þ7, þ8, -5, and -7). In conclusion, these results provide interesting insights into the speciﬁcity of cellular protein carbonylation associated with cell death and the effect of surrounding amino acids on modiﬁcation frequencies. References  Bollineni, R.; Hoffmann, R.; Fedorova, M.; Identiﬁcation of protein carbonylation sites by two-dimensional liquid chromatography in combination with MALDIand ESI-MS. J Proteomics 74 (2011) 2338-2350; 2011.
Roles for hypoxia inducible factor 1 and glucose metabolism in tumor cell survival following photodynamic therapy Mans Broekgaarden a, Milan Kos a, Ruud Weijer a, Massis Krekorian a,b, Thomas M. van Gulik a, Michal Heger a
Department of Experimental Surgery, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands